Company intelligence / Profile preview

KLB Gesundheitsforschung Lübeck GmbH

Lübeck, Germany

Ownership: Private
Development stage: Other

Overview

KLB Gesundheitsforschung Lübeck GmbH, founded in 2008, was a clinical research site specializing in conducting Phase I-IV trials for respiratory diseases such as bronchial asthma, COPD, and pulmonary fibrosis. It was acquired by Velocity Clinical Research in 2024 and subsequently rebranded.

Therapeutic areas: ImmunologyPulmonology
Industry: Contract Research Organization

Beyond the preview

Go deeper on KLB Gesundheitsforschung Lübeck GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLB Gesundheitsforschung Lübeck GmbH.

Explore the full profile